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Abstract
© 2017 Somia Lassed et al. Green tea (GT) has been studied for its effects as antioxidant and
cancer-preventive agent. Epidemiological studies showed that GT consumption decreases the
risk  for  prostate  cancer  (PC).  To  investigate  whether  erythrocyte  oxidative  stress  (OS)  is
associated with PC and whether daily consumption of GT improves the oxidative phenotype, we
performed a  study  in  a  group of  Algerian  PC patients,  preceded by  an  in  vitro  study  to
characterize  composition  and  antioxidant/antiproliferative  activities  of  the  GT  used.  This
contained  a  high  content  of  phenolic  and  flavonoid  compounds,  demonstrating  in  vitro
antioxidant activity and significant antiproliferative effect on human prostate cancer PC-3 cell
line. Seventy PC patients and 120 age-matched healthy subjects participated in the study, with
glutathione (GSH), malondialdehyde (MDA), and catalase activity evaluated before and after GT
consumption. The results showed a reduced GSH and catalase activity and a high level of MDA
in erythrocytes from PC patients. The consumption of 2-3 cups per day of GT during 6 months
significantly  increased  GSH  concentration  and  catalase  activity  and  decreased  MDA
concentration. In conclusion, GT significantly decreased OS in Algerian PC patients. Regular
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